Crystal Adam
Insider CIK 1825445 · CCCC Chief Medical Officer · TNGX See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics, Inc. | M Exercise deriv | 2026-10-01 | 2026-10-05 | 27,000 | — | $0 | 233,040 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-05 | 600 | $25.32 | $15.2K | 115,743 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-05 | 26,400 | $24.45 | $645.6K | 116,343 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise | 2026-10-01 | 2026-10-05 | 27,000 | $5.20 | $140.4K | 142,743 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise deriv | 2026-09-01 | 2026-09-03 | 27,000 | — | $0 | 260,040 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise | 2026-09-01 | 2026-09-03 | 27,000 | $5.20 | $140.4K | 142,743 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 27,000 | $22.37 | $604.0K | 115,743 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise deriv | 2026-09-01 | 2026-09-03 | 27,000 | — | $0 | 260,040 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 27,000 | $22.37 | $603.9K | 115,743 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise | 2026-09-01 | 2026-09-03 | 27,000 | $5.20 | $140.4K | 142,743 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise deriv | 2026-08-03 | 2026-08-05 | 27,000 | — | $0 | 287,040 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise | 2026-08-03 | 2026-08-05 | 27,000 | $5.20 | $140.4K | 142,743 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 5,267 | $26.79 | $141.1K | 137,476 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 21,733 | $27.35 | $594.4K | 115,743 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise deriv | 2026-08-03 | 2026-08-05 | 27,000 | — | $0 | 287,040 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 21,733 | $27.35 | $594.4K | 115,743 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 5,267 | $26.79 | $141.1K | 137,476 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise | 2026-08-03 | 2026-08-05 | 27,000 | $5.20 | $140.4K | 142,743 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise deriv | 2026-07-01 | 2026-07-02 | 27,000 | — | $0 | 314,040 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-02 | 19,629 | $29.34 | $575.9K | 123,114 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-02 | 7,371 | $30.25 | $223.0K | 115,743 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise | 2026-07-01 | 2026-07-02 | 27,000 | $5.20 | $140.4K | 142,743 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise deriv | 2026-06-01 | 2026-06-03 | 27,000 | — | $0 | 341,040 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-06-01 | 2026-06-03 | 6,140 | $22.25 | $136.6K | 136,603 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-06-01 | 2026-06-03 | 20,860 | $23.06 | $481.0K | 115,743 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise | 2026-06-01 | 2026-06-03 | 27,000 | $5.20 | $140.4K | 142,743 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise deriv | 2026-05-01 | 2026-05-05 | 27,000 | — | $0 | 368,040 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-05-01 | 2026-05-05 | 1,100 | $22.00 | $24.2K | 115,743 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise | 2026-05-01 | 2026-05-05 | 27,000 | $5.20 | $140.4K | 142,743 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-05-01 | 2026-05-05 | 25,900 | $21.19 | $548.8K | 116,843 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise deriv | 2026-04-15 | 2026-04-16 | 38,460 | — | $0 | 395,040 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-04-15 | 2026-04-16 | 38,460 | $25.00 | $961.5K | 112,622 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise | 2026-04-15 | 2026-04-16 | 38,460 | $5.20 | $200.0K | 151,082 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise deriv | 2026-04-01 | 2026-04-02 | 27,000 | — | $0 | 433,500 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise | 2026-04-01 | 2026-04-02 | 27,000 | $5.20 | $140.4K | 139,622 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-02 | 27,000 | $21.20 | $572.4K | 112,622 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise deriv | 2026-03-25 | 2026-03-27 | 12,000 | — | $0 | 460,500 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-03-25 | 2026-03-27 | 12,000 | $20.11 | $241.3K | 112,622 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | M Exercise | 2026-03-25 | 2026-03-27 | 12,000 | $5.20 | $62.4K | 124,622 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-03-05 | 2026-03-09 | 20,251 | $15.00 | $303.8K | 112,622 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-02-25 | 2026-02-27 | 54,345 | $12.77 | $694.0K | 132,873 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-02-03 | 2026-02-04 | 18,251 | $12.26 | $223.8K | 187,419 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-02-03 | 2026-02-04 | 201 | $12.90 | $2.6K | 187,218 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-04 | 284,760 | — | $0 | 284,760 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2026-02-02 | 2026-02-04 | 47,460 | — | $0 | 205,670 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2025-02-05 | 2025-02-06 | 6,851 | $3.16 | $21.6K | 158,210 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2025-02-04 | 2025-02-06 | 7,432 | $2.99 | $22.2K | 165,061 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2025-02-03 | 2025-02-05 | 318,090 | — | $0 | 318,090 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2025-02-03 | 2025-02-05 | 53,015 | — | $0 | 172,493 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-02-07 | 2024-02-08 | 4,083 | $12.62 | $51.5K | 119,478 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-02-06 | 2024-02-08 | 4,288 | $12.56 | $53.9K | 123,561 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 279,593 | — | $0 | 279,593 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2024-02-01 | 2024-02-05 | 46,599 | — | $0 | 46,599 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2023-11-01 | 2023-11-02 | 7,507 | $8.39 | $63.0K | 81,250 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2023-03-01 | 2023-03-02 | 487,500 | — | $0 | 487,500 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2023-03-01 | 2023-03-02 | 81,250 | — | $0 | 81,250 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2023-01-30 | 2023-02-01 | 3,750 | — | $0 | 18,750 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2023-01-30 | 2023-02-01 | 1,301 | $7.78 | $10.1K | 20,097 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2023-01-30 | 2023-02-01 | 3,750 | — | $0 | 21,398 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2022-05-26 | 2022-06-14 | 1,102 | $7.01 | $7.7K | 17,648 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2022-05-25 | 2022-05-27 | 3,750 | — | $0 | 22,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2022-05-25 | 2022-05-27 | 3,750 | — | $0 | 18,750 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2022-02-14 | 2022-02-16 | 26,250 | — | $0 | 26,250 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2022-02-14 | 2022-02-16 | 118,000 | — | $0 | 118,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2022-01-04 | 2022-01-05 | 15,000 | — | $0 | 112,292 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 13,946 | $31.59 | $440.6K | 16,054 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 1,054 | $32.66 | $34.4K | 15,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2022-01-04 | 2022-01-05 | 15,000 | $6.49 | $97.3K | 30,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-12-22 | 2021-12-23 | 5,000 | — | $0 | 127,292 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-12-22 | 2021-12-23 | 5,000 | $6.49 | $32.5K | 15,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-10-08 | 2021-10-12 | 10,000 | — | $0 | 132,292 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-10-08 | 2021-10-12 | 10,000 | $6.49 | $64.9K | 10,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-10-01 | 2021-10-05 | 15,000 | — | $0 | 168,108 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-10-01 | 2021-10-05 | 15,000 | $4.98 | $74.7K | 15,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | S Sale | 2021-10-01 | 2021-10-05 | 5,112 | $45.99 | $235.1K | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | S Sale | 2021-10-01 | 2021-10-05 | 1,712 | $44.25 | $75.8K | 13,288 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | S Sale | 2021-10-01 | 2021-10-05 | 8,176 | $45.32 | $370.5K | 5,112 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-07-29 | 2021-08-02 | 15,000 | — | $0 | 183,108 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-07-29 | 2021-08-02 | 15,000 | $4.98 | $74.7K | 15,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | S Sale | 2021-07-29 | 2021-08-02 | 15,000 | $45.00 | $675.0K | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-07-01 | 2021-07-06 | 15,000 | — | $0 | 142,292 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-07-01 | 2021-07-06 | 15,000 | $6.50 | $97.5K | 15,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | S Sale | 2021-07-01 | 2021-07-06 | 13,300 | $37.93 | $504.5K | 1,700 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | S Sale | 2021-07-01 | 2021-07-06 | 1,700 | $38.38 | $65.2K | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-04-05 | 2021-04-06 | 15,000 | — | $0 | 157,292 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | S Sale | 2021-04-05 | 2021-04-06 | 10,879 | $38.00 | $413.4K | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-04-05 | 2021-04-06 | 15,000 | $6.50 | $97.5K | 15,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | S Sale | 2021-04-05 | 2021-04-06 | 4,121 | $37.16 | $153.1K | 10,879 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2021-02-11 | 2021-02-16 | 87,850 | — | $0 | 87,850 | SEC↗ |